Evolent Health
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $444,328 | $483,649 | $646,542 | $621,401 |
Gross Profit | 77,244 | 102,471 | 75,711 | 80,693 |
EBITDA | 14,020 | -28,705 | 13,287 | 11,955 |
EBIT | -9,121 | -52,763 | -17,203 | -17,746 |
Net Income | -51,090 | -64,618 | -22,802 | -23,137 |
Net Change In Cash | 444,328 | 483,649 | 646,542 | 621,401 |
Free Cash Flow | -39,104 | -4,030 | -32,382 | 12,381 |
Cash | 150,995 | 246,547 | 104,203 | 96,583 |
Basic Shares | 115,882 | 115,315 | 115,032 | 114,862 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,554,741 | $1,963,896 | $1,352,013 | $907,957 |
Gross Profit | 367,353 | 460,470 | 316,584 | 250,406 |
EBITDA | 84,854 | -24,785 | 43,746 | 55,661 |
EBIT | -38,314 | -148,200 | -46,505 | -4,376 |
Net Income | -61,623 | -113,040 | -19,164 | -30,801 |
Net Change In Cash | 2,554,741 | 1,963,896 | 1,352,013 | 907,957 |
Cost of Revenue | -139,127 | -6,587 | ||
Free Cash Flow | -6,128 | 113,837 | -49,914 | 13,764 |
Cash | 104,203 | 192,825 | 188,200 | 266,280 |
Basic Shares | 114,682 | 111,251 | 93,699 | 86,067 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.10 |
2025-03-31 | $0.06 |
2024-12-31 | -$0.02 |
